{{Rsnum
|rsid=16977065
|Gene=RIT2
|Chromosome=18
|position=42857686
|Orientation=plus
|GMAF=0.09137
|Gene_s=RIT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 53.7 | 41.2 | 5.1
| JPT | 62.8 | 30.1 | 7.1
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 53.7 | 41.2 | 5.1
| CHD | 60.7 | 33.6 | 5.6
| GIH | 87.1 | 12.9 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 67.2 | 31.0 | 1.7
| MKK | 0.0 | 0.0 | 0.0
| TSI | 97.1 | 2.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=1E-7
|OR=33.7200
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}